These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27517156)
1. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1. Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156 [TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes. Viaud J; Zeghouf M; Barelli H; Zeeh JC; Padilla A; Guibert B; Chardin P; Royer CA; Cherfils J; Chavanieu A Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10370-5. PubMed ID: 17563369 [TBL] [Abstract][Full Text] [Related]
3. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions. Schlienger S; Ramirez RA; Claing A Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216 [TBL] [Abstract][Full Text] [Related]
4. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells. Lewis-Saravalli S; Campbell S; Claing A Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487 [TBL] [Abstract][Full Text] [Related]
5. Recruitment of Arf1-GDP to Golgi by Glo3p-type ArfGAPs is crucial for golgi maintenance and plant growth. Min MK; Jang M; Lee M; Lee J; Song K; Lee Y; Choi KY; Robinson DG; Hwang I Plant Physiol; 2013 Feb; 161(2):676-91. PubMed ID: 23266962 [TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458 [TBL] [Abstract][Full Text] [Related]
7. Podosome assembly is controlled by the GTPase ARF1 and its nucleotide exchange factor ARNO. Rafiq NB; Lieu ZZ; Jiang T; Yu CH; Matsudaira P; Jones GE; Bershadsky AD J Cell Biol; 2017 Jan; 216(1):181-197. PubMed ID: 28007915 [TBL] [Abstract][Full Text] [Related]
8. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. Boulay PL; Cotton M; Melançon P; Claing A J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689 [TBL] [Abstract][Full Text] [Related]
9. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225 [TBL] [Abstract][Full Text] [Related]
10. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics. Lang L; Shay C; Zhao X; Teng Y J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537 [TBL] [Abstract][Full Text] [Related]
11. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling. Luchsinger C; Aguilar M; Burgos PV; Ehrenfeld P; Mardones GA PLoS One; 2018; 13(4):e0195401. PubMed ID: 29614107 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the Arf1*GTP/Arf GAP interface reveals an Arf1 mutant that selectively affects the Arf GAP ASAP1. Luo R; Jacques K; Ahvazi B; Stauffer S; Premont RT; Randazzo PA Curr Biol; 2005 Dec; 15(23):2164-9. PubMed ID: 16332543 [TBL] [Abstract][Full Text] [Related]
13. IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells. Münzberg C; Höhn K; Krndija D; Maaß U; Bartsch DK; Slater EP; Oswald F; Walther P; Seufferlein T; von Wichert G J Cell Mol Med; 2015 May; 19(5):948-59. PubMed ID: 25754106 [TBL] [Abstract][Full Text] [Related]
14. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells. Haines E; Saucier C; Claing A J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288 [TBL] [Abstract][Full Text] [Related]
15. Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis. Hanai A; Ohgi M; Yagi C; Ueda T; Shin HW; Nakayama K J Biochem; 2016 Feb; 159(2):201-8. PubMed ID: 26330566 [TBL] [Abstract][Full Text] [Related]
16. An Arf1 GTPase mutant with different responses to GEF inhibitors. Flisiak S; Zeeh JC; Guibert B; Cherfils J; Zeghouf M Biochem Biophys Res Commun; 2008 Dec; 377(1):156-60. PubMed ID: 18834864 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance. Tsai MM; Lin PY; Cheng WL; Tsai CY; Chi HC; Chen CY; Tseng YH; Cheng YF; Chen CD; Liang Y; Liao CJ; Wu SM; Lin YH; Chung IH; Wang CS; Lin KH Cancer Sci; 2012 Jun; 103(6):1136-44. PubMed ID: 22348287 [TBL] [Abstract][Full Text] [Related]
18. Recruitment to Golgi membranes of ADP-ribosylation factor 1 is mediated by the cytoplasmic domain of p23. Gommel DU; Memon AR; Heiss A; Lottspeich F; Pfannstiel J; Lechner J; Reinhard C; Helms JB; Nickel W; Wieland FT EMBO J; 2001 Dec; 20(23):6751-60. PubMed ID: 11726511 [TBL] [Abstract][Full Text] [Related]
19. AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy. Ohashi Y; Iijima H; Yamaotsu N; Yamazaki K; Sato S; Okamura M; Sugimoto K; Dan S; Hirono S; Yamori T J Biol Chem; 2012 Feb; 287(6):3885-97. PubMed ID: 22158626 [TBL] [Abstract][Full Text] [Related]
20. Correct targeting of plant ARF GTPases relies on distinct protein domains. Matheson LA; Suri SS; Hanton SL; Chatre L; Brandizzi F Traffic; 2008 Jan; 9(1):103-20. PubMed ID: 17988226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]